Effectiveness of Medical Taping Concept in Cancer Patients

Miguel Hernández University of Elche

Status and phase: Unknown; Early Phase 1

Conditions: Cancer-related Problem/Condition

Treatments: Device: Cure Tape™ away from dermatomes T 7 and T 8; Device: Cure Tape™ covering T 7 and T 8 dermatomes

Study type: Interventional

Funder types: Other

Identifiers

NCT02823314

16/308

Details and patient eligibility

About

Nausea and vomiting are two of the side effects associated with the most common antineoplastic chemotherapy treatments. The Medical Taping Concept (MTC) is an economical technique, easy to apply. This is a technique that may help reduce nausea and vomiting after application of chemotherapy in cancer patient.

Full description

Nausea and vomiting are two of the side effects associated with the most common antineoplastic chemotherapy treatments. There are some studies that support the use of physical measures such as TENS or acupuncture to lessen these effects.

The Medical Taping Concept (MTC) is an economical technique, easy to apply and few side effects. In some manuals on this technique the possibility that it may act to reduce nausea and vomiting described. Sim But after a comprehensive literature search have not found jobs to support these assumptions. With this work, the research team will attempt to obtain evidence on the effects of its application in the areas of influence of the dermatome T7 and T8. For this, two adhesive tapes of this type of bandage is placed on the front and back on a group of patients after receiving chemotherapy session and compared with a control group that will apply this technique outside the dermatome indicated . Both groups will receive antiemetics according to the service routine. If the hypothesis were positive it could extend the application of this simple technique to cancer patients from other centers in order to help reduce nausea and vomiting.

Enrollment: 20 estimated patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Neoadjuvant and adjuvant breast cancer
• To have been diagnosed with a severe comorbid disorder
• To have received at least the first cycle of emetogenic chemotherapy

Exclusion criteria

• Not suffer nausea or vomiting episodes in the previous cycle of chemotherapy,
• To Shower inability to report nausea and / or vomiting.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

20 participants in 2 patient groups, including a placebo group

Intervention group

Experimental group

Description:

One piece of a special hypoallergenic adhesive tape, called Cure Tape®, they will have a size of 12-20 cm and will be attached in the front and back torso area on the T7- T8 dermatomes.

Treatment:

Device: Cure Tape™ covering T 7 and T 8 dermatomes

Placebo group

Placebo Comparator group

Description:

Two piece of a special hypoallergenic adhesive tape, called Cure Tape®, have a size of 2.5 cm x 2 cm and they will have to be placed near the greater trochanter area.

Treatment:

Device: Cure Tape™ away from dermatomes T 7 and T 8